Innovation & Entrepreneurship News

The pharmaceutical company GlaxoSmithKline (GSK) today announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will be used to explore how gene mutations cause disease, potentially yielding new technologies using CRISPR that would rapidly accelerate the discovery of new medicines.

UC Berkeley is renowned for its history of rebellion, upsetting the status quo and stretching the limits of the way things ought to be. That reputation, when viewed from the outside, has often been seen as negative. But a new ranking listing Berkeley as the No. 1 public school in the world for funded founders — business and tech startups that attract funding almost from inception — suggests Berkeley has turned those qualities into positives.

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers faster and more efficiently than ever. This optical “traffic cop” could one day revolutionize how information travels through data centers and high-performance supercomputers that are used for artificial intelligence and other data-intensive applications.

A team of engineers at the UC Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.

The University of California announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent Number 10,227,611 covering use of single-molecule RNA guides and Cas9 protein in any cell, thus creating efficient and effective ways for scientists to target and edit genes.

With support from the Bakar Fellows Program, David Schaffer is working on one of the first gene therapies to be approved for clinical use. The therapy acts to restore vision in children with a rare and previously incurable disease called Leber's congenital amaurosis type 2.

It’s still some years off, but Steven Conolly aims to see disease in a totally new way. He leads research on an emerging Magnetic Particle Imaging (MPI) technology that already can peer past tissue or organs to detect disease deep within the body.

Nearly 40 percent of women worldwide stop using birth control pills within a year – mainly due to side effects such as depression, weight gain, bleeding between periods and blood clots. Research by Polina Lishko on a non-hormonal contraceptive is showing promise as a new birth control alternative.

The U.S. Patent and Trademark Office has issued a notice of allowance for a University of California patent application covering systems and methods for using single molecule guide RNAs that, when combined with the Cas9 protein, create more efficient and effective ways for scientists to target and edit genes.

Cloud applications and the ever-increasing demand by large enterprises to transmit and analyze “big data” are stretching the capacity of even the largest data center servers as traditional switches become data flow bottlenecks. Ming Wu has invented a new optical, or photonic, switch capable of record-breaking speed that can be fabricated as integrated circuits so they can be mass-produced, keeping the cost per device low.

Self-driving cars may one day do more than just get us from point A to point B. By adjusting their speed and position while they merge they could also help reduce the bottlenecks and random slowdowns on busy thoroughfares like the Bay Bridge, getting us where we’re going faster and more efficiently than if we all drove ourselves.